Married father of three boys in a sports-centric household. Growing up in SoCal it was about the water; surfing, water skiing and ocean fishing. Now living in Colorado it’s been about the mountains; hiking, snow skiing and stream fishing. The outdoors is my playground. I’m also a big local sports supporter – CU Buffs, Broncos, Nuggets, Rockies, and Avalanche.
Mike is a senior executive in the biotechnology industry. During his career in biotechnology Mike has been affiliated with the development of four pharmaceutical products approved by the FDA; AmBisome, DaunoXome, Macugen and most recently, Folotyn.
He has raised over $300 million in debt and equity financing, completed over $700 million in acquisitions, led his company through an IPO and served as President, CEO and a Director of Allos Therapeutics, Inc..
Mike is currently Chief Operating Officer of Bolder BioTechnology, Inc., a private protein therapeutics company, and serves on the board of directors of Affygility Solutions, an environmental, health and safety services provider. He also is an industry advisor to the Boulder Innovation Center and the University of Colorado Technology Transfer Office.
Mike holds a BA in Business Economics and a BA in Geography from University of California, Santa Barbara. He received his MBA from California State University, Fresno.